Daiwa Securities Group Inc. - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 283 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$17
-34.6%
4470.0%0.00%
Q1 2024$26
-10.3%
447
-7.8%
0.00%
Q4 2023$29
+81.2%
485
+15.8%
0.00%
Q3 2023$16
-57.9%
4190.0%0.00%
Q2 2023$38
+31.0%
419
-5.8%
0.00%
Q1 2023$29
+26.1%
4450.0%0.00%
Q4 2022$23
-99.9%
445
+12.1%
0.00%
Q3 2022$27,000
+50.0%
3970.0%0.00%
Q2 2022$18,000
+20.0%
397
+33.2%
0.00%
Q1 2022$15,000
+7.1%
2980.0%0.00%
Q4 2021$14,000
+40.0%
2980.0%0.00%
Q3 2021$10,0000.0%298
+87.4%
0.00%
Q2 2021$10,000
+42.9%
1590.0%0.00%
Q1 2021$7,000
-12.5%
159
+12.0%
0.00%
Q4 2020$8,000
-38.5%
142
-66.1%
0.00%
Q3 2020$13,000
+18.2%
4190.0%0.00%
Q2 2020$11,0000.0%4190.0%0.00%
Q1 2020$11,0000.0%419
+16.1%
0.00%
Q4 2019$11,000
+10.0%
361
-9.3%
0.00%
Q3 2019$10,0000.0%3980.0%0.00%
Q2 2019$10,000
+42.9%
398
+11.2%
0.00%
Q1 2019$7,0000.0%358
-28.4%
0.00%
Q4 2018$7,0005000.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 624,962$20,599,00013.29%
Octagon Capital Advisors LP 1,595,911$52,601,00012.95%
Logos Global Management LP 1,450,000$47,792,0003.45%
Avoro Capital Advisors LLC 5,000,000$164,800,0002.59%
Ghost Tree Capital, LLC 200,000$6,592,0001.93%
Integral Health Asset Management, LLC 190,000$6,262,0001.80%
GREAT POINT PARTNERS LLC 200,000$6,592,0001.54%
Aufman Associates Inc 53,642$1,768,0001.45%
Ghost Tree Capital, LLC 150,000$4,944,0001.45%
Altium Capital Management LP 166,700$5,494,0001.44%
View complete list of APELLIS PHARMACEUTICALS INC shareholders